Increased Nf levels in the CSF and blood are indicators of neuroaxonal injury and are used to monitor disease severity in various neurological disorders including amyotrophic lateral sclerosis, Parkinson disease, and the neurotoxicity of immune checkpoint inhibitors (19, 20). This evidence concerns the gene NFASC and Parkinson disease.